rs28408173
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000378585.7(GABRD):c.816C>T(p.Ser272=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.15 in 1,569,906 control chromosomes in the GnomAD database, including 20,692 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 1800 hom., cov: 34)
Exomes 𝑓: 0.15 ( 18892 hom. )
Consequence
GABRD
ENST00000378585.7 synonymous
ENST00000378585.7 synonymous
Scores
6
Clinical Significance
Conservation
PhyloP100: -0.476
Genes affected
GABRD (HGNC:4084): (gamma-aminobutyric acid type A receptor subunit delta) Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. The GABA-A receptor is generally pentameric and there are five types of subunits: alpha, beta, gamma, delta, and rho. This gene encodes the delta subunit. Mutations in this gene have been associated with susceptibility to generalized epilepsy with febrile seizures, type 5. Alternatively spliced transcript variants have been described for this gene, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=4.3176806E-5).
BP6
Variant 1-2029235-C-T is Benign according to our data. Variant chr1-2029235-C-T is described in ClinVar as [Benign]. Clinvar id is 256825.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-2029235-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.476 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.417 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRD | NM_000815.5 | c.816C>T | p.Ser272= | synonymous_variant | 7/9 | ENST00000378585.7 | NP_000806.2 | |
GABRD | XM_017000936.2 | c.1521C>T | p.Ser507= | synonymous_variant | 6/8 | XP_016856425.1 | ||
GABRD | XM_011541194.4 | c.855C>T | p.Ser285= | synonymous_variant | 7/9 | XP_011539496.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRD | ENST00000378585.7 | c.816C>T | p.Ser272= | synonymous_variant | 7/9 | 1 | NM_000815.5 | ENSP00000367848 | P1 |
Frequencies
GnomAD3 genomes AF: 0.126 AC: 19216AN: 152184Hom.: 1790 Cov.: 34
GnomAD3 genomes
AF:
AC:
19216
AN:
152184
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.192 AC: 35320AN: 184166Hom.: 4375 AF XY: 0.195 AC XY: 19180AN XY: 98252
GnomAD3 exomes
AF:
AC:
35320
AN:
184166
Hom.:
AF XY:
AC XY:
19180
AN XY:
98252
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.152 AC: 215491AN: 1417604Hom.: 18892 Cov.: 33 AF XY: 0.154 AC XY: 108357AN XY: 701504
GnomAD4 exome
AF:
AC:
215491
AN:
1417604
Hom.:
Cov.:
33
AF XY:
AC XY:
108357
AN XY:
701504
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.126 AC: 19243AN: 152302Hom.: 1800 Cov.: 34 AF XY: 0.132 AC XY: 9853AN XY: 74478
GnomAD4 genome
AF:
AC:
19243
AN:
152302
Hom.:
Cov.:
34
AF XY:
AC XY:
9853
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
461
ALSPAC
AF:
AC:
531
ESP6500AA
AF:
AC:
141
ESP6500EA
AF:
AC:
1123
ExAC
AF:
AC:
18364
Asia WGS
AF:
AC:
1140
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 27, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Idiopathic generalized epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MutationTaster
Benign
P
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at